Even more even more, a company called Ocugen attempted to seek approval for a whole-virus vaccine (Covaxin) from India with apparently a good safety profile and effectiveness in trials, but it was slow-walked by the FDA and never approved (or at least not approved during the relevant period, like 2021). Between that and throwing J+J under the bus, it became clear that the real goal was to get that specific mRNA sequence into every life form on the planet, whether for profit or more sinister reasons.